CAS No.
[152459-95-5(Unlabeled)]
Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide-13CD3
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Imatinib-13C,d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Imatinib-13C,d3 usage and description
Imatinib 13C D3 is a highly specialized drug that is used in the treatment of certain types of cancer, specifically chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting the activity of tyrosine kinases, which are enzymes that play a crucial role in the growth and spread of cancer cells.
The chemical formula of Imatinib 13C D3 is C29H28N7O3S, and it is a deuterated form of the drug Imatinib, which means that it contains three stable isotopes of carbon (13C) in its molecular structure. This makes it useful for researchers and pharmacologists who wish to study the drug's metabolism and pharmacokinetics in the human body.
Imatinib 13C D3 is typically administered orally in the form of a tablet or capsule, and it is generally well-tolerated by patients. However, like all medications, it may cause certain side effects such as nausea, vomiting, diarrhea, fatigue, and muscle cramps.
In conclusion, Imatinib 13C D3 is a powerful and effective drug that has revolutionized the treatment of certain types of cancer. Its unique chemical structure makes it an important tool for researchers and pharmacologists who wish to better understand its mechanism of action and its effects on the human body.
